Sharrp Ventures leads 100 CR investment in Naturis Cosmetics’ first institutional funding round

▴ Rahul Tandon, CEO of Naturis Cosmetics
The new influx of capital will enable manufacturing expansion and R&D capabilities.

India-wide release, 16 July 2026: India’s leading CDMO player in the fast-growing beauty & personal care (BPC) sector, Naturis Cosmetics, has raised INR 100 crore in its first external funding round. The investment was led by Sharrp Ventures, with participation from Mirabilis Investment Trust (Infosys Co-founder K. Dinesh Family Office), financial growth equity investors Anicut Capital and Niveshaay, D2C ecosystem leaders including Suyash Saraf (Hyperscale Ventures) and Yogesh Kabra, along with several prominent angel investors from pharma and specialty chemical ecosystems. 

Naturis Cosmetics is an R&D-led manufacturing company with a track record of enabling 50+ category-winning D2C and leading BPC brands in India, including Pilgrim, Purplle, Nykaa, Asaya, Hoop, Colorbar, Innovist’s Bare Anatomy, Kay Beauty, and Antinorm, amongst others. The Mumbai-based company also partners with several pharmaceutical companies like Glenmark and Dr. Reddy’s Laboratories for new-age OTC and cosmeceuticals backed by unique technologies. 

The fresh capital will enable Naturis Cosmetics to accelerate its vision of leading the next decade of innovation and growth in the BPC sector. It aims to become the platform of choice for beauty, personal care, and wellness brands across D2C, FMCG, and OTC pharma. The company also plans to expand its geographical presence across the country by establishing a new state-of-the-art production unit in Vapi, spanning 225,000 sq. ft, an experience centre in the NCR region, and a new R&D centre in Mumbai. Additionally, it will significantly scale its team across verticals. 

Over the next five years, Naturis intends to diversify into high-growth categories, including men’s grooming, body care, colour cosmetics, fragrances, and exports, while strengthening its capabilities in OTC pharma. The company also plans to deepen its innovation funnels with both existing and new brands. 

Commenting on the funds raised, Rahul Tandon, Co-Founder & CEO of Naturis Cosmetics, said, “Our long-term vision is to build India’s leading ODM platform in the BPC space. This investment is not just a vote of confidence in Naturis, but also in India’s manufacturing and innovation ecosystem. With the strategic expertise of our investors and partners, we are well-positioned to accelerate our growth, strengthen our R&D capabilities, expand our manufacturing footprint, and help build the next generation of brands from India. We are grateful for the trust our investors have placed in us and remain committed to building the backbone of the industry through innovation, agility, and integrity.”

Divya Gupta, Principal at Sharrp Ventures, added, “What stood out to us about Naturis was its ability to combine deep formulation and product development capability with strong quality systems and a customer-first way of working. Its customers see Naturis not just as a supplier, but as a partner of choice, which has enabled the company to scale rapidly while delivering strong financial performance. As Naturis grows, we believe it has the potential to become a trusted product innovation and manufacturing platform for domestic and global brands. We are happy to partner with the team in its journey of building an enduring institution.”

Furthermore, Mr. Sagar Kandhari, Partner at Ambassador Capital Partners, advised Naturis Cosmetics through its fundraising process and has joined the company’s Board to support its next phase of strategic growth and scale-up.

India’s beauty and personal care industry is entering a period of unprecedented growth. As per a recent Redseer Report, the country will be the fourth-largest beauty and personal care (BPC) market globally, growing to $40 billion by 2030. This is driven by rising consumer awareness, higher disposable incomes, and easy accessibility. Consequently, the demand for innovation-led manufacturing partners is also growing significantly. 

A profitable company with a revenue growth of 50%+ CAGR over the last four years, Naturis Cosmetics is well-positioned to lead this next phase of growth. The move marks a significant milestone not just for the company, but for India’s rapidly evolving beauty and personal care manufacturing ecosystem. Bringing together institutional investors, family offices, and experienced operators from the D2C and healthcare sectors, this first-of-its-kind investment reflects growing confidence in the manufacturing infrastructure, building a robust backbone of India’s BPC sector.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

What Happens to Your Body During an All-Nighter?August 06, 2026
Childhood Obesity in India: A Growing Public Health Crisis That Demands Urgent AttentionAugust 06, 2026
Screen Time Effects on Children: What Every Indian Parent and Paediatrician Needs to KnowAugust 06, 2026
Kidney Transplant Recipient Defeats CancerAugust 05, 2026
Fermenta Biotech Lists on India’s National Stock ExchangeAugust 05, 2026
Asia Pacific leaders warn attacks against health and gender are undoing decades of progressAugust 05, 2026
Understanding Long-Term Impacts of Air Purification on ImmunityAugust 05, 2026
Understanding Epigenetics: How Lifestyle Changes Your DNAAugust 05, 2026
CARE Hospitals to Offer Free Vascular Health Check on National Vascular DayAugust 05, 2026
Breastfeeding Myths That New Mothers Should Stop BelievingAugust 05, 2026
Why Modern Lifestyle Causes Chronic InflammationAugust 05, 2026
Endometriosis Awareness: Understanding the Silent Condition Affecting Millions of Indian WomenAugust 05, 2026
A Complete Guide to Pregnancy Health Tips for Indian Women: Nutrition, Wellness, and What Every Expectant Mother Should KnowAugust 05, 2026
Metropolis Healthcare reports strong Q1FY27 performance, with revenue up 17% to ₹450 crore and EBITDA up 27% YoYAugust 04, 2026
India's Silent Liver Health Crisis: New Data Points to Urgent Need for Screening and PreventionAugust 04, 2026
Eureka Forbes Launches 'Ghar Ka New Favourite' Campaign showcasing Forbes SmartClean Robotic Vacuum Cleaner with Shraddha KapoorAugust 04, 2026
Why Preventive Healthcare for Children Is One of the Most Important Investments India Can MakeAugust 04, 2026
The Role of Pathology in Healthcare: From Diagnosis to Disease PreventionAugust 04, 2026
Pathophysiology of Psoriatic Arthritis: Clinical Presentation, Joint Damage Mitigation, and BiologicsAugust 04, 2026
Comprehensive Evaluation of Syncope: Cardiac vs. Neurological Origin WorkupsAugust 04, 2026